Oxazepam Capsule, Gelatin Coated
FDA Label NDC 62584-814

29 label sections · Submitted to the FDA by American Health Packaging · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by American Health Packaging for the product Oxazepam (NDC 62584-814). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, warning: risks from concomitant use with opioids; abuse, misuse, and addiction; and dependence and withdrawal reactions, description, clinical pharmacology, indications, contraindications, warnings, general, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Packaging Information

American Health Packaging unit dose blisters (see How Supplied section) contain drug product from Teva Pharmaceuticals as follows:
(10 mg / 100 UD) NDC 62584-812-01 packaged from NDC 0228-2067
(15 mg / 100 UD) NDC 62584-813-01 packaged from NDC 0228-2069
(30 mg / 100 UD) NDC 62584-814-01 packaged from NDC 0228-2073

Distributed by:
American Health Packaging
Columbus, OH 43217

8081301/0124F

Package/Label Display Panel – Blister – 10 Mg

10 mg Oxazepam Capsule Blister (10 mg Oxazepam Capsule Blister)

10 mg Oxazepam Capsule Blister (10 mg Oxazepam Capsule Blister)

Oxazepam
Capsule, USP    CIV

10 mg

Package/Label Display Panel – Blister – 15 Mg

15 mg Oxazepam Capsule Blister (15 mg Oxazepam Capsule Blister)

15 mg Oxazepam Capsule Blister (15 mg Oxazepam Capsule Blister)

Oxazepam
Capsule, USP    CIV

15 mg

Package/Label Display Panel – Blister – 30 Mg

30 mg Oxazepam Capsule Blister (30 mg Oxazepam Capsule Blister)

30 mg Oxazepam Capsule Blister (30 mg Oxazepam Capsule Blister)

Oxazepam
Capsule, USP    CIV

30 mg

* Please review the disclaimer below.